FI115826B - Terapeuttinen aine rasva-aineenvaihdunnan häiriöön - Google Patents
Terapeuttinen aine rasva-aineenvaihdunnan häiriöön Download PDFInfo
- Publication number
- FI115826B FI115826B FI963312A FI963312A FI115826B FI 115826 B FI115826 B FI 115826B FI 963312 A FI963312 A FI 963312A FI 963312 A FI963312 A FI 963312A FI 115826 B FI115826 B FI 115826B
- Authority
- FI
- Finland
- Prior art keywords
- tcf
- therapeutic agent
- cholesterol
- disorder
- serum
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP33788494 | 1994-12-27 | ||
JP6337884A JPH08176007A (ja) | 1994-12-27 | 1994-12-27 | 脂質代謝異常治療剤 |
JP9502707 | 1995-12-27 | ||
PCT/JP1995/002707 WO1996020004A1 (en) | 1994-12-27 | 1995-12-27 | Therapeutic agent for disorder of lipid metabolism |
Publications (3)
Publication Number | Publication Date |
---|---|
FI963312A0 FI963312A0 (fi) | 1996-08-26 |
FI963312A FI963312A (fi) | 1996-08-26 |
FI115826B true FI115826B (fi) | 2005-07-29 |
Family
ID=18312906
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI963312A FI115826B (fi) | 1994-12-27 | 1996-08-26 | Terapeuttinen aine rasva-aineenvaihdunnan häiriöön |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP0754051B1 (no) |
JP (1) | JPH08176007A (no) |
KR (1) | KR100395695B1 (no) |
AT (1) | ATE247975T1 (no) |
AU (1) | AU710513B2 (no) |
CA (1) | CA2184248A1 (no) |
DE (1) | DE69531608T2 (no) |
DK (1) | DK0754051T3 (no) |
ES (1) | ES2201128T3 (no) |
FI (1) | FI115826B (no) |
HU (1) | HU220139B (no) |
NO (1) | NO318099B1 (no) |
NZ (1) | NZ298141A (no) |
TW (1) | TW480173B (no) |
WO (1) | WO1996020004A1 (no) |
ZA (1) | ZA9510981B (no) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4006058B2 (ja) | 1997-03-11 | 2007-11-14 | 第一三共株式会社 | 多臓器不全予防及び/又は治療剤 |
KR100568664B1 (ko) * | 1997-03-14 | 2006-06-13 | 다이이치세이야꾸 가부시끼가이샤 | 악액질 예방 및/또는 치료제 |
WO1998041230A1 (fr) * | 1997-03-14 | 1998-09-24 | Snow Brand Milk Products Co., Ltd. | Agent preventif et/ou curatif de la cachexie |
DE69836626T2 (de) | 1997-04-11 | 2007-04-05 | Takeda Pharmaceutical Co. Ltd. | Proteine mit lecithin-cholesterin acetyltransferase-ähnlicher aktivität, deren herstellung und verwendung |
JPH1129493A (ja) * | 1997-07-14 | 1999-02-02 | Snow Brand Milk Prod Co Ltd | 放射線障害予防及び/又は治療剤 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ232813A (en) * | 1989-03-10 | 1992-08-26 | Snow Brand Milk Products Co Ltd | Human fibroblast glycoprotein, cell differentiation, blood vessel endothelial cell growth factor, cellular immunology inforcing factor of 78 or 74 thousand daltons plus or minus two thousand daltons |
DE69334281D1 (de) * | 1992-07-16 | 2009-05-28 | Daiichi Sankyo Co Ltd | TCF-II enthaltende medizinische Zusammensetzung |
-
1994
- 1994-12-27 JP JP6337884A patent/JPH08176007A/ja not_active Withdrawn
- 1994-12-27 NZ NZ298141A patent/NZ298141A/xx not_active IP Right Cessation
-
1995
- 1995-12-16 TW TW084113453A patent/TW480173B/zh not_active IP Right Cessation
- 1995-12-27 AT AT95942270T patent/ATE247975T1/de not_active IP Right Cessation
- 1995-12-27 AU AU43550/96A patent/AU710513B2/en not_active Ceased
- 1995-12-27 EP EP95942270A patent/EP0754051B1/en not_active Expired - Lifetime
- 1995-12-27 DE DE69531608T patent/DE69531608T2/de not_active Expired - Fee Related
- 1995-12-27 ES ES95942270T patent/ES2201128T3/es not_active Expired - Lifetime
- 1995-12-27 WO PCT/JP1995/002707 patent/WO1996020004A1/en active IP Right Grant
- 1995-12-27 KR KR1019960704608A patent/KR100395695B1/ko not_active IP Right Cessation
- 1995-12-27 CA CA002184248A patent/CA2184248A1/en not_active Abandoned
- 1995-12-27 DK DK95942270T patent/DK0754051T3/da active
- 1995-12-27 ZA ZA9510981A patent/ZA9510981B/xx unknown
- 1995-12-27 HU HU9602341A patent/HU220139B/hu not_active IP Right Cessation
-
1996
- 1996-08-26 FI FI963312A patent/FI115826B/fi active IP Right Grant
- 1996-08-26 NO NO19963551A patent/NO318099B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ZA9510981B (en) | 1996-07-17 |
DE69531608D1 (de) | 2003-10-02 |
EP0754051B1 (en) | 2003-08-27 |
JPH08176007A (ja) | 1996-07-09 |
FI963312A0 (fi) | 1996-08-26 |
NZ298141A (en) | 2000-12-22 |
AU710513B2 (en) | 1999-09-23 |
DK0754051T3 (da) | 2003-09-29 |
WO1996020004A1 (en) | 1996-07-04 |
DE69531608T2 (de) | 2004-02-19 |
CA2184248A1 (en) | 1996-07-04 |
HU9602341D0 (en) | 1996-10-28 |
NO318099B1 (no) | 2005-01-31 |
KR970701058A (ko) | 1997-03-17 |
FI963312A (fi) | 1996-08-26 |
NO963551D0 (no) | 1996-08-26 |
AU4355096A (en) | 1996-07-19 |
KR100395695B1 (ko) | 2004-02-14 |
HU220139B (hu) | 2001-11-28 |
TW480173B (en) | 2002-03-21 |
ES2201128T3 (es) | 2004-03-16 |
NO963551L (no) | 1996-10-25 |
HUT76085A (en) | 1997-06-30 |
EP0754051A1 (en) | 1997-01-22 |
ATE247975T1 (de) | 2003-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Guarnieri et al. | Lipid-lowering effect of carnitine in chronically uremic patients treated with maintenance hemodialysis | |
Vatassery et al. | Effect of high doses of dietary vitamin E on the concentrations of vitamin E in several brain regions, plasma, liver, and adipose tissue of rats | |
Norton et al. | In vivo utilization of substrate by human sarcoma‐bearing limbs | |
US4703062A (en) | Parenteral nutrition with medium and long chain triglycerides | |
JPH09512552A (ja) | 腎疾患および不全の治療方法ならびに組成物 | |
EP0321128A1 (en) | Fatty acid compositions | |
Yamazaki et al. | Changes in fatty acid composition in rat blood and organs after infusion of eicosapentaenoic acid ethyl ester | |
FI115826B (fi) | Terapeuttinen aine rasva-aineenvaihdunnan häiriöön | |
KR19990076920A (ko) | L-카르노신을 함유하는 신부전증 치료용 조성물 | |
US5021239A (en) | Use of M-CSF to improve lipoprotein cholesterol profiles | |
KR20010101616A (ko) | 진세노사이드 Rb₁을 함유하는 뇌혈관 재생ㆍ재구축촉진제 및 신경조직 이차변성 억제제 | |
CA2100720C (en) | Medicinal composition comprising tcf-ii | |
Brousseau | Emerging role of high-density lipoprotein in the prevention of cardiovascular disease | |
Ney et al. | Alteration in lipoprotein composition with intravenous compared to intragastric fat-free feeding in the rat | |
Foss et al. | Lipoatrophy produced in mice and rabbits by a fraction prepared from the urine from patients with congenital generalized lipodystrophy | |
WO1985003002A1 (en) | Parenteral nutrition with medium and long chain triglycerides | |
Warner et al. | Ketogenic and antiketogenic effects of L-carnitine in hemodialysis patients. | |
EP0459377A2 (en) | Use of E1 prostaglandin to cure male erectile inpotence | |
Salako et al. | The effects of porcine calcitonin on renal function in the rabbit | |
MXPA02000912A (es) | Uso de l-carnitina y sus derivados alcanoilo para la preparacion de un medicamento util para el tratamiento de pacientes que sufren nefropatias diabeticas o por insuficiencia metabolica. | |
JP2006160757A (ja) | 脂質代謝異常治療剤 | |
WO1994027629A1 (en) | Method to control appetite and treat obesity | |
KR0156623B1 (ko) | 상피세포 손상 치료용 조성물 | |
Ishida et al. | The protective effects of SA3443, a novel cyclic disulfide, on chronic liver injuries in rats | |
Mulroney et al. | Suppression of growth hormone release restores phosphaturic response to PTH in immature rats |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Patent granted |
Ref document number: 115826 Country of ref document: FI |
|
PC | Transfer of assignment of patent |
Owner name: ATLAS PHARMACEUTICALS INC. Free format text: ATLAS PHARMACEUTICALS INC. |